Literature DB >> 19693298

Contemporary therapy of acute ST-elevation myocardial infarction.

Paul W Armstrong1.   

Abstract

Entities:  

Keywords:  Angioplasty, transluminal, percutaneous coronary/standards; clinical protocols; community health planning; electrocardiography; fibrinolysis; fibrinolytic agents; myocardial infarction/therapy; myocardial reperfusion; risk assessment; risk reduction behavior; thrombolytic therapy; time factors

Mesh：

Substances：

Year:  2009        PMID： 19693298      PMCID： PMC2720296     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  28 in total

1.  Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.

Authors:  Philippe Gabriel Steg; Eric Bonnefoy; Sylvie Chabaud; Frédéric Lapostolle; Pierre-Yves Dubien; Pascal Cristofini; Alain Leizorovicz; Paul Touboul
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

Review 2.  Fibrinolysis for acute myocardial infarction: the future is here and now.

Authors:  Paul W Armstrong; Désiré Collen; Elliott Antman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

3.  Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol.

Authors:  Henry H Ting; Charanjit S Rihal; Bernard J Gersh; Luis H Haro; Christine M Bjerke; Ryan J Lennon; Choon-Chern Lim; John F Bresnahan; Allan S Jaffe; David R Holmes; Malcolm R Bell
Journal:  Circulation       Date:  2007-08-01       Impact factor: 29.690

4.  Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2.

Authors:  Cheuk-Kit Wong; Wanzhen Gao; O Christopher Raffel; John K French; Ralph A Stewart; Harvey D White
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

5.  AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Association of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons.

Authors:  Randal J Thomas; Marjorie King; Karen Lui; Neil Oldridge; Ileana L Piña; John Spertus; Robert O Bonow; N A Mark Estes; David C Goff; Kathleen L Grady; Ann R Hiniker; Frederick A Masoudi; Martha J Radford; John S Rumsfeld; Gayle R Whitman
Journal:  J Am Coll Cardiol       Date:  2007-10-02       Impact factor: 24.094

Review 6.  Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction.

Authors:  Paul W Armstrong; Cynthia M Westerhout; Robert C Welsh
Journal:  Circulation       Date:  2009-03-10       Impact factor: 29.690

7.  ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine.

Authors:  Harlan M Krumholz; Jeffrey L Anderson; Brian L Bachelder; Francis M Fesmire; Stephan D Fihn; Joanne M Foody; P Michael Ho; Mikhail N Kosiborod; Frederick A Masoudi; Brahmajee K Nallamothu
Journal:  Circulation       Date:  2008-11-10       Impact factor: 29.690

8.  Outcome in patients transferred for percutaneous coronary intervention (a national registry of myocardial infarction 2/3/4 analysis).

Authors:  David M Shavelle; M Leila Rasouli; Paul Frederick; C Michael Gibson; William J French
Journal:  Am J Cardiol       Date:  2005-09-02       Impact factor: 2.778

9.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction).

Authors:  Elliott M. Antman; Daniel T. Anbe; Paul Wayne Armstrong; Eric R. Bates; Lee A. Green; Mary Hand; Judith S. Hochman; Harlan M. Krumholz; Frederick G. Kushner; Gervasio A. Lamas; Charles J. Mullany; Joseph P. Ornato; David L. Pearle; Michael A. Sloan; Sidney C. Smith; Joseph S. Alpert; Jeffrey L. Anderson; David P. Faxon; Valentin Fuster; Raymond J. Gibbons; Gabriel Gregoratos; Jonathan L. Halperin; Loren F. Hiratzka; Sharon Ann Hunt; Alice K. Jacobs; Joseph P. Ornato
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

10.  Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.

Authors:  Paul W Armstrong; Yuling Fu; Cynthia M Westerhout; Michael P Hudson; Kenneth W Mahaffey; Harvey D White; Thomas G Todaro; Peter X Adams; Philip E G Aylward; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2009-04-28       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.